More Business Wire
View Older Stories View Newer Stories-
CIBL, Inc. Reports (Unaudited) Third Quarter Operating Results
-
DataCore Software Unveils Next-Gen Capabilities in SANsymphony and Swarm Storage Offerings
-
Ciena Reports Fiscal Fourth Quarter 2023 Financial Results
-
Laser Photonics Receives Order From Lufthansa Technik for CleanTech Laser Cleaning System
-
Sarah Cannon Research Institute to Present Latest Research Insights at the 2023 ASH Annual Meeting & Exposition
-
Shorla Oncology Welcomes Rayna Sethi Herman as Chief Commercial Officer
-
Komodo Health Adds 90M Closed Lives Per Year To Expansive Healthcare Map
-
DCM Repays Balance of $30 million Term Loan from Sale of its Fergus, Ontario Facility for Gross Proceeds of $6.75 Million
-
Northisle Announces Non-Brokered Private Placement
-
Belka Games Releases New Merge and Tycoon Game Roger That!
-
Fonon Corporation Expands Its Product Offering With Strategic Acquisition of Fonon Technologies
-
Lobe Sciences Provides Update on L-130 Clinical Program
-
Babson Diagnostics’ BetterWay™ Blood Testing Service Achieves Critical Milestone Ahead of Commercialization
-
CPI Card Group Announces Share Purchase Agreement with Majority Shareholder Parallel49 Equity ULC
-
Cleveland-Cliffs is Featured in the U.S. Department of Energy Better Climate Challenge Road Show
-
Daniel Martin Joins Pipedrive as VP of Customer Experience
-
Flow Beverage Corp. to Attend Roth MKM’s 12th Annual Deer Valley Event
-
Ameresco Begins Construction with Sunel on Sonnedix’s 300MW of Design-Build Solar Park Projects Across the UK
-
Philanthropist MacKenzie Scott Awards Capital Link with $3M Grant to Support the Nation’s Community Health Centers
-
Carlisle Companies Releases Vision 2030 Strategy and Financial Targets
-
SIXT Named Best Car Rental Company in North America at Annual Business Traveler Awards
-
Virtus Investment Partners Declares Quarterly Cash Dividend on Common Stock
-
Good Times Restaurants to Release Fourth Quarter Financial Results on December 14, 2023
-
Quectel launches SG520B series of 5G Sub-6GHz smart modules with powerful multimedia functionality
-
Bristol Myers Squibb Announces Phase 3 CheckMate -8HW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Compared to Chemotherapy in Microsatellite Instability–High or Mismatch Repair Defi
-
Dollar General Corporation Reports Third Quarter 2023 Results
-
Ryder Earns Military Times' 2023 Best for Vets Designation
-
Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility
-
Ferguson Files Form 10-Q
-
Owens & Minor Launches Life Takes Care™
-
U.S. Urology Partners Announces Partnership with Greater Boston Urology
-
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update
-
Nextdoor Rewind: 2023 Gives Neighbors a Local-Level Reflection of the Past Year Together
-
Philip Morris International Inc. Declares Regular Quarterly Dividend of $1.30 Per Share
-
Apogee Enterprises Announces Date for Fiscal 2024 Third Quarter Financial Results
-
Bristol Myers Squibb Announces Additional $3 Billion Share Repurchase Authorization
-
BJ’s Wholesale Club Announces December 15 Grand Opening for Lewis Center
-
Global Perma-Crisis Set to Drastically Impact Employee Wellbeing in 2024, as 80% Predict Burnout Will Have a Significant Effect on Businesses – International SOS Risk Outlook 2024
-
PUMA x VIVID VISIONS by Andrew Burgess: a Textile-to-Textile Fashion Experiment
-
Global Blue Releases the Monthly Tax Free Shopping Business Update for November 2023
-
SEQSTER Launches CoRD™ (Connected Research & Development) Accelerating Drug Discovery and Deep Insights for Pharma
-
St. John and Store By Store Debut Restaurant Marketing Podcast “Smart Takes”
-
GMS Reports Second Quarter Fiscal 2024 Results
-
PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023
-
Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung
-
Bigleaf Networks Honored with Prestigious Product of the Year Award by Business Intelligence Group
-
Krach Institute for Tech Diplomacy at Purdue Names Winners of its 2023 Freedom Scholarship
-
Sonatus Launches New Software Solution to Help Automakers Realize the Full Potential of SDVs
-
Avaya Helps UK and Ireland Enterprises Deliver AI-Powered Innovation Without Disruption
-
APOLLO Insurance Announces 1,000th Embedded Integration to Distribute Digital Insurance Products
